Cincor Pharma Inc (CINC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 292,557 | 127,620 | 164,602 | 136,606 | N/A |
| Marketable Securities | 229,940 | 166,692 | 149,558 | N/A | N/A |
| TOTAL | $529,019 | $302,975 | $321,648 | $141,107 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 100 | 41 | N/A | N/A | N/A |
| TOTAL | $100 | $41 | $N/A | $N/A | $N/A |
| Total Assets | $529,119 | $303,016 | $321,648 | $141,107 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,588 | 2,095 | 4,369 | 650 | 0 |
| Accrued Expenses | 7,593 | 5,187 | 1,317 | 5,263 | N/A |
| Other current liabilities | N/A | N/A | N/A | 10,637 | N/A |
| TOTAL | $10,182 | $7,282 | $5,686 | $16,549 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $10,182 | $7,282 | $5,686 | $16,549 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,764 | 37,739 | 37,710 | N/A | N/A |
| Retained earnings | -136,453 | -115,475 | -94,400 | -77,703 | N/A |
| Other shareholders' equity | -883 | -712 | -318 | 188,275 | 0 |
| TOTAL | $518,938 | $295,734 | $315,962 | $124,558 | $N/A |
| Total Liabilities And Equity | $529,119 | $303,016 | $321,648 | $141,107 | $0 |